Drugs / ETEC/rCTB vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02556996 | Oct 1998 → Mar 2001 | diarrheal disease | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ETEC/rCTB vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02556996 ↗ |
| Known as | killed ETEC/rCTB vaccine | “The vaccine consists of a mixture of five formalin-killed ETEC bacteria expressing prevalent ETEC colonization factors and recombinant cholera toxin B-subunit (killed ETEC/rCTB...” NCT02556996 ↗ |
| Modality | Vaccine | “oral, inactivated whole-cell enterotoxigenic Escherichia coli (ETEC) vaccine” NCT02556996 ↗ |
| Route | Oral | “Three doses administered orally at 2-week intervals” NCT02556996 ↗ |